Bicocca Open Archive

Logo unimib boa
FUMAGALLI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.445
AS - Asia 4.764
EU - Europa 3.571
Continente sconosciuto - Info sul continente non disponibili 796
SA - Sud America 641
AF - Africa 111
OC - Oceania 28
Totale 18.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.942
SG - Singapore 1.680
CN - Cina 1.024
IT - Italia 865
VN - Vietnam 674
HK - Hong Kong 610
RU - Federazione Russa 558
DE - Germania 509
BR - Brasile 474
SE - Svezia 452
CA - Canada 443
GB - Regno Unito 281
IE - Irlanda 270
FR - Francia 165
IN - India 158
BD - Bangladesh 119
KR - Corea 89
UA - Ucraina 83
ID - Indonesia 75
TR - Turchia 69
FI - Finlandia 68
DK - Danimarca 67
AR - Argentina 65
JP - Giappone 49
NL - Olanda 40
AT - Austria 38
ZA - Sudafrica 38
LT - Lituania 35
MX - Messico 34
IQ - Iraq 33
ES - Italia 27
PL - Polonia 27
BE - Belgio 24
CO - Colombia 24
SA - Arabia Saudita 24
AU - Australia 23
EC - Ecuador 23
PK - Pakistan 23
EG - Egitto 19
PH - Filippine 19
CH - Svizzera 16
VE - Venezuela 16
PY - Paraguay 14
ET - Etiopia 13
KZ - Kazakistan 12
IR - Iran 11
MY - Malesia 11
UZ - Uzbekistan 11
TN - Tunisia 10
JO - Giordania 9
TW - Taiwan 9
RO - Romania 8
UY - Uruguay 8
CL - Cile 7
HR - Croazia 7
MA - Marocco 7
NP - Nepal 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
IL - Israele 6
TH - Thailandia 6
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
EU - Europa 5
OM - Oman 5
PA - Panama 5
PT - Portogallo 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
DZ - Algeria 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
LY - Libia 3
PE - Perù 3
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GY - Guiana 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
NO - Norvegia 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 17.552
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.897
Singapore 1.034
Dallas 610
Ashburn 590
Hong Kong 588
San Jose 478
Toronto 356
Milan 353
Wilmington 347
Chandler 323
Frankfurt am Main 289
Dublin 262
Dearborn 236
New York 197
Los Angeles 188
Woodbridge 185
Ho Chi Minh City 175
Santa Clara 158
Houston 157
Hanoi 144
Fairfield 139
Beijing 136
Princeton 134
Nanjing 113
Chicago 112
Boardman 104
Jacksonville 90
The Dalles 77
Council Bluffs 74
Seattle 71
Guangzhou 67
Moscow 65
Lauterbourg 63
Seoul 62
Rome 60
Jakarta 53
Buffalo 50
Shanghai 50
Basingstoke 46
Nanchang 42
Orem 42
Dong Ket 41
São Paulo 40
Cambridge 38
Helsinki 37
Lawrence 32
Munich 31
Vienna 31
Columbus 30
Shenyang 29
Vilnius 28
Da Nang 27
Altamura 26
Hangzhou 25
Chennai 24
Hefei 24
Zhengzhou 24
Atlanta 23
Brooklyn 22
Denver 22
Montreal 22
Phoenix 22
Pune 22
Shangdi 21
Tokyo 21
Haiphong 20
Jinan 20
Brussels 19
London 19
Ottawa 19
Warsaw 19
Portland 18
Rio de Janeiro 18
Sacramento 18
Kunming 17
Manchester 17
Sydney 17
Baghdad 16
Changsha 16
Tianjin 16
Andover 15
Fremont 15
Falls Church 14
Johannesburg 14
Kent 14
Kocaeli 14
Mainz 14
Poplar 14
Stockholm 14
Addis Ababa 13
Belo Horizonte 13
Redondo Beach 13
San Francisco 13
Boston 12
Dhaka 12
Edmonton 12
Ha Long 12
Hải Dương 12
Mexico City 12
Nuremberg 12
Totale 11.412
Salva come PNG Salva come JPEG
Nome #
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 469
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 460
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 456
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 437
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 417
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 406
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 399
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 389
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 387
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 375
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 348
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 336
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 333
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 330
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 328
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 327
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 316
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 308
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 305
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 302
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 300
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 297
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 288
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 284
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 282
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 280
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 275
Multimodal experimental approach to the study of human neurological diseases 270
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 265
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 261
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 252
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 251
Genetic factors influencing the development of vincristine-induced neurotoxicity 251
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 241
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 236
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 235
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 235
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 230
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 227
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 222
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 218
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 217
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 217
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 213
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 213
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 213
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 212
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 211
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 211
In vitro neurotoxicity of new promising metal-based anticancer complexes 208
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 208
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 207
Pharmacokinetics of IVIg in Wistar rats 206
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 206
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 204
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 204
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 202
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 196
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 191
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 190
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 182
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 178
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 178
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 171
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 168
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 166
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 160
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 135
Blood NfL as a potential axonal damage marker in different CIPN rat models. 135
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 126
Totale 18.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.662
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.773 139 363 248 115 236 92 189 97 286 396 222 390
2025/20267.116 754 464 855 581 633 388 1.070 314 530 556 516 455
2026/2027161 161 0 0 0 0 0 0 0 0 0 0 0
Totale 18.356